2014 Prevention Research Center Award Recipients
The Student Athlete Project:
Professor Tamera Hew-Butler, D.P.M., PhD is using the DEXA scan to assess pre and post-season changes in body composition in athletes ingesting a protein supplement (Muscle Milk™) during and after daily training sessions. In this observational study, she and her team are assessing the potential benefits (↑ muscle mass, ↑ strength, ↓ fat, ↓ injuries) versus the potential risks (toxic metal accumulation, gastrointestinal discomfort, renal problems) of protein supplementation. The Oakland University athletes are already participating in the “Performance Fueling Project”, which began in November 2012.
More Pictures of the Student Athlete Project!
Kristin Landis-Piwowar, Ph.D., Assistant Professor of Biomedical Diagnostic and Therapeutic Sciences (BDTS), received funding to begin experiments in her cancer biology research lab located in the recently opened Human Health Building. Landis-Piwowar will assess how peptidomimetics, a novel class of anti-cancer drug, enter cancer cells and to identify the mechanisms by which those cells are eventually destroyed. She hopes her research will reveal how to specifically attack cancer cells while sparing the healthy cells in a patient’s body. Ultimately, her goal is to utilize molecularly targeted anti-cancer agents to minimize the adverse toxic effects that patients experience from traditional chemotherapy. In addition to her lab work, Landis-Piwowar has been published in journals such as Cancer Research and Current Cancer Drug Targets. . Two of her recent publications in Clinical Laboratory Science are titled, “Advances in Clinical Cancer Research” and “Proteasome Inhibitors in Cancer Therapy: A Novel Approach to a Ubiquitous Problem.”
Metabolic Syndrome Study (one example).....
Retrospective analysis of clinical records for members participating in Oakland University-based health assessment/fitness (25 years)
- 878 members analyzed
- 15% presented with metabolic syndrome
- Within two years, 42% resolved their metabolic syndrome status
- Elevated triglycerides characterized those participants who did not improve
- For those who resolved, there was a 33% improvement in triglycerides level.